End Alzheimer's with IKU & MakerDAO

241 Centre St

241 Centre St · New York, NY

How to find us

Between Broome and Grand- 5TH FLOOR

Location image of event venue



Big Pharma has given up on the search to cure Alzheimer’s. But we don’t have to!

IKU is partnering with MakerDAO to create the first IKU Neuro DRO (decentralized research organization) to stop Alzheimer’s and neurodegenerative disease. We are tokenizing the IP of a scientific breakthrough, a new BIOMARKER, that may end Alzheimer's Disease and establish the foundation of the NeuroDRO.

The DRO - an open p2p digital network where contributors can have as little, or as much SKIN IN THE GAME as they like - will develop and own the research addressing the prevention of neuro-degeneration.

The beauty here is that we already have a scientific breakthrough to seed the DRO, as well as the necessary clinical trial lined up to execute by CRO Prodrome Sciences, with research supported by:

• University of Pennsylvania

• Duke University

• Alzheimer's Association

• U.S. National Institutes of Health

• SENS Research Foundation

While we are initially focused on Alzheimer's, the scientific breakthrough has significant implications on neuro-degeneration, including dementia, multiple sclerosis, Parkinson's, stroke and aging generally.

Join us May 17th where we'll be discussing how blockchain, MakerDAO's DAI stable coin, and the research itself made this whole thing come together. Drinks, music and cutting edge neuroscience will be provided.

Find out more info about the DRO and the research here: https://alz.iku.network/


Gregory J. Rigano, Esq. - IKU
Founder & CEO
Blockchain: The NeurDRO

Jessica Salomon - MakerDAO
Business Development
DeFi: DAI - The Exclusive Stable Coin

Dr. Dayan Goodenowe, PhD - Prodrome Sciences
Founder & CEO
Neuro-degeneration & Alzheimer's: Thinking Outside the Box